A novel retinoid-regulated gene, tazarotene-induced gene 3 (TIG3), also known as retinoic acid receptor responder 3 (RARRES3, accession number AF 060228), has tumor-suppressive effects [231]. The gene discussed is PLAAT4; the disease is neoplasm.